Development · 30 Oct 2026
CANBK, full dossier2 publishers have reported this development. Each act of reporting is below, cited.
Cemindia Projects Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 to consider and approve the Unaudited (Standalone And Consolidated) Financial Results for the quarter and half year ended 30th September, 2026.
Aarti Pharmalabs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 to consider and approve Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30, 2026.
Bharat Electronics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 to consider and approve Unaudited Financial Results for the quarter ended 30.09.2026.
NTPC Ltd informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 to consider and approve Un-audited Financial Results for the quarter and half year ended 30th September 2026 and Declaration of 1st interim dividend, if any, for the Financial Year 2026-27.
REC Ltd informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 to consider and approve financial results for the quarter and half year ended September 30, 2026 and 2nd Interim Dividend for the financial year 2026-27, if any.
Paras Defence And Space Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results For The Quarter Ended September 30, 2026.
Bharat Petroleum Corporation Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026.
Vineet Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 to consider and approve the unaudited Standalone Financial Results of the Company for the first quarter ended on June 30, 2026 along with the Limited Review Report.
OneSource Specialty Pharma Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27-Oct-2026 to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
RIR Power Electronics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 to consider and approve Un-audited Standalone Financial Results for the second quarter and half year ended 30th September, 2026.
Andhra Pradesh Tanneries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2026 to consider and approve unaudited results for the quarter ended on 30.9.2026.
The meeting of the Board of Directors of Indus Towers Ltd is scheduled on 27/10/2026 to consider and approve the Audited Financial Results (Standalone & Consolidated) for the second quarter (Q2) and half year ended on September 30, 2026.
Ambuja Cements Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 to consider and approve the Un-audited Financial Results for the Quarter and Half Year ended September 30, 2026.
The meeting of the Board of Directors of Multi Commodity Exchange Of India Ltd is scheduled on November 3, 2026, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2026.
The meeting of the Board of Directors of Bajaj Finserv Ltd is scheduled on 03/11/2026 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended 30 September 2026.
21 Oct 2026 · 1 publisher
Rising government bond yields pose a potential mark-to-market provisioning risk for Canara Bank.
20 Oct 2026 · 1 publisher
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.